{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:19:34Z","timestamp":1757625574443,"version":"3.44.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP23K14993"],"award-info":[{"award-number":["JP23K14993"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["24FC1009"],"award-info":[{"award-number":["24FC1009"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010391","name":"Tokyo Women's Medical University","doi-asserted-by":"publisher","award":["Tokyo Women's Medical University"],"award-info":[{"award-number":["Tokyo Women's Medical University"]}],"id":[{"id":"10.13039\/501100010391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The optimal timing for mesenchymal stem cell (MSC) therapy in Duchenne muscular dystrophy (DMD) remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Neonatal DMD rats received intraperitoneal adipose-derived MSCs according to three schedules: early (postnatal days 1 and 14), continuous (days 1, 14, 28, and 42), or late (days 28 and 42). Wild-type rats and untreated DMD rats served as controls. Functional and histological outcomes were assessed on day 56.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Continuous administration significantly attenuated the decline in grip strength across ten consecutive measurements (\u2212\u200911% vs. \u221237% in DMD controls), and also reduced serum creatine kinase levels and diaphragmatic fibrosis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Early or late treatment alone showed limited benefit. GFP-labelled cells were rarely detected in muscle, indicating minimal engraftment and suggesting paracrine-mediated effects. Molecular profiling showed lower CDKN2A together with higher CDKN1A, IL-10, VEGF-A and IGF-1 in the continuous group, revealing an anti-senescence, pro-regenerative profile that paralleled the functional gains.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Early and sustained MSC administration offers superior structural and functional protection in DMD rats, highlighting the importance of treatment timing in maximizing therapeutic efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13287-025-04594-x","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:39:47Z","timestamp":1756215587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuous adipose-derived stem cell therapy from the neonatal stage effectively reduces Duchenne muscular dystrophy symptoms in rats"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9355-5397","authenticated-orcid":false,"given":"Yuki","family":"Kihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanari","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"4594_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7:13.","journal-title":"Nat Rev Dis Primers"},{"key":"4594_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41573-023-00775-6","volume":"22","author":"TC Roberts","year":"2023","unstructured":"Roberts TC, Wood MJA, Davies KE. Therapeutic approaches for Duchenne muscular dystrophy. Nat Rev Drug Discov. 2023;22:917\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"4594_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mus.23831","volume":"48","author":"RC Griggs","year":"2013","unstructured":"Griggs RC, Herr BE, Reha A, Elfring G, Atkinson L, Cwik V, et al. Corticosteroids in Duchenne muscular dystrophy: major variations in practice. Muscle Nerve. 2013;48:27\u201331.","journal-title":"Muscle Nerve"},{"key":"4594_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.omtm.2022.08.009","volume":"27","author":"KM Flanigan","year":"2022","unstructured":"Flanigan KM, Vetter TA, Simmons TR, Iammarino M, Frair EC, Rinaldi F, et al. A first-in-human phase i\/iia gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2. Mol Ther Methods Clin Dev. 2022;27:47\u201360.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4594_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JND-220811","volume":"9","author":"PR Clemens","year":"2022","unstructured":"Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, McDonald CM, et al. Long-term functional efficacy and safety of viltolarsen in patients with Duchenne muscular dystrophy. J Neuromuscul Dis. 2022;9:493\u2013501.","journal-title":"J Neuromuscul Dis"},{"key":"4594_CR6","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.3233\/JND-210678","volume":"8","author":"N Elangkovan","year":"2021","unstructured":"Elangkovan N, Dickson G. Gene therapy for Duchenne muscular dystrophy. J Neuromuscul Dis. 2021;8:S303\u201316.","journal-title":"J Neuromuscul Dis"},{"key":"4594_CR7","first-page":"Cd003725","volume":"2016","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;2016:Cd003725.","journal-title":"Cochrane Database Syst Rev"},{"key":"4594_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/14653240802020381","volume":"10","author":"SW Feng","year":"2008","unstructured":"Feng SW, Lu XL, Liu ZS, Zhang YN, Liu TY, Li JL, et al. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into Mdx mice. Cytotherapy. 2008;10:254\u201364.","journal-title":"Cytotherapy"},{"key":"4594_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00005-022-00656-7","volume":"70","author":"M Siemionow","year":"2022","unstructured":"Siemionow M, Brodowska S, Langa P, Zalants K, Kozlowska K, Grau-Kazmierczak W, et al. Long-term biodistribution and safety of human dystrophin expressing chimeric cell therapy after systemic-intraosseous administration to Duchenne muscular dystrophy model. Arch Immunol Ther Exp (Warsz). 2022;70:20.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"4594_CR10","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/mt.2016.163","volume":"24","author":"C Sitzia","year":"2016","unstructured":"Sitzia C, Farini A, Jardim L, Razini P, Belicchi M, Cassinelli L, et al. Adaptive immune response impairs the efficacy of autologous transplantation of engineered stem cells in dystrophic dogs. Mol Ther. 2016;24:1949\u201364.","journal-title":"Mol Ther"},{"key":"4594_CR11","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1093\/hmg\/ddv316","volume":"24","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhu Y, Li Y, Cao J, Zhang H, Chen M, et al. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice. Hum Mol Genet. 2015;24:6029\u201340.","journal-title":"Hum Mol Genet"},{"key":"4594_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","volume":"399","author":"CM McDonald","year":"2022","unstructured":"McDonald CM, Marb\u00e1n E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, et al. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022;399:1049\u201358.","journal-title":"Lancet"},{"key":"4594_CR13","first-page":"63","volume":"8","author":"A Dai","year":"2018","unstructured":"Dai A, Baspinar O, Ye\u015filyurt A, Sun E, Aydemir \u00c7, \u00d6ztel ON, et al. Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-II. Degener Neurol Neuromuscul Dis. 2018;8:63\u201377.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"4594_CR14","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s12015-023-10530-4","volume":"19","author":"A Heydemann","year":"2023","unstructured":"Heydemann A, Bieganski G, Wachowiak J, Czarnota J, Niezgoda A, Siemionow K, et al. Dystrophin expressing chimeric (DEC) cell therapy for Duchenne muscular dystrophy: a first-in-human study with minimum 6 months follow-up. Stem Cell Rev Rep. 2023;19:1340\u201359.","journal-title":"Stem Cell Rev Rep"},{"key":"4594_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/biomedicines9091089","volume":"9","author":"SE Park","year":"2021","unstructured":"Park SE, Jeong JB, Oh SJ, Kim SJ, Kim H, Choi A, et al. Wharton\u2019s jelly-derived mesenchymal stem cells reduce fibrosis in a mouse model of Duchenne muscular dystrophy by upregulating MicroRNA 499. Biomedicines. 2021;9:1089.","journal-title":"Biomedicines"},{"key":"4594_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1056\/NEJMoa2030391","volume":"384","author":"A Arakawa","year":"2021","unstructured":"Arakawa A, Ichikawa H, Kubo T, Motoi N, Kumamoto T, Nakajima M, et al. Vaginal transmission of cancer from mothers with cervical cancer to infants. N Engl J Med. 2021;384:42\u201350.","journal-title":"N Engl J Med"},{"key":"4594_CR17","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1038\/srep05635","volume":"4","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Fujii W, Tsuboi M, Tanihata J, Teramoto N, Takeuchi S, et al. Generation of muscular dystrophy model rats with a crispr\/cas system. Sci Rep. 2014;4:5635.","journal-title":"Sci Rep"},{"key":"4594_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3171\/2018.11.JNS182331","volume":"132","author":"B Ryu","year":"2019","unstructured":"Ryu B, Sekine H, Homma J, Kobayashi T, Kobayashi E, Kawamata T, et al. Allogeneic adipose-derived mesenchymal stem cell sheet that produces neurological improvement with angiogenesis and neurogenesis in a rat stroke model. J Neurosurg. 2019;132:442\u201355.","journal-title":"J Neurosurg"},{"key":"4594_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00441-020-03315-5","volume":"383","author":"S Mohamed-Ahmed","year":"2021","unstructured":"Mohamed-Ahmed S, Yassin MA, Rashad A, Espedal H, Idris SB, Finne-Wistrand A, et al. Comparison of bone regenerative capacity of donor-matched human adipose-derived and bone marrow mesenchymal stem cells. Cell Tissue Res. 2021;383:1061\u201375.","journal-title":"Cell Tissue Res"},{"key":"4594_CR20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3389\/fphar.2019.01695","volume":"10","author":"AES Brooks","year":"2019","unstructured":"Brooks AES, Iminitoff M, Williams E, Damani T, Jackson-Patel V, Fan V, et al. Ex vivo human adipose tissue derived mesenchymal stromal cells (ASC) are a heterogeneous population that demonstrate rapid culture-induced changes. Front Pharmacol. 2019;10:1695.","journal-title":"Front Pharmacol"},{"key":"4594_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.reth.2022.04.006","volume":"20","author":"Y Kihara","year":"2022","unstructured":"Kihara Y, Homma J, Takagi R, Ishigaki K, Nagata S, Yamato M. Laminin-221-derived recombinant fragment facilitates isolation of cultured skeletal myoblasts. Regenerative Therapy. 2022;20:147\u201356.","journal-title":"Regenerative Therapy"},{"key":"4594_CR22","doi-asserted-by":"crossref","unstructured":"Agarwal M, Sharma A, Kumar P, Kumar A, Bharadwaj A, Saini M et al. Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. Development. 2020;147.","DOI":"10.1242\/dev.184507"},{"key":"4594_CR23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133:1019\u201331.","journal-title":"Cell"},{"key":"4594_CR24","doi-asserted-by":"crossref","unstructured":"Tominaga K, Suzuki HI. TGF-\u03b2 signaling in cellular senescence and aging-related pathology. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20205002"},{"key":"4594_CR25","doi-asserted-by":"publisher","first-page":"16385","DOI":"10.1038\/s41598-020-73315-6","volume":"10","author":"H Sugihara","year":"2020","unstructured":"Sugihara H, Teramoto N, Nakamura K, Shiga T, Shirakawa T, Matsuo M, et al. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy. Sci Rep. 2020;10:16385.","journal-title":"Sci Rep"},{"key":"4594_CR26","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1084\/jem.20042224","volume":"201","author":"AM Rodriguez","year":"2005","unstructured":"Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne JY, Wdziekonski B, et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent Mdx mouse. J Exp Med. 2005;201:1397\u2013405.","journal-title":"J Exp Med"},{"key":"4594_CR27","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3727\/096368911X","volume":"21","author":"NM Vieira","year":"2012","unstructured":"Vieira NM, Valadares M, Zucconi E, Secco M, Bueno CR Jr., Brandalise V, et al. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Cell Transpl. 2012;21:1407\u201317.","journal-title":"Cell Transpl"},{"key":"4594_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1479-5876-6-35","volume":"6","author":"I Kerkis","year":"2008","unstructured":"Kerkis I, Ambrosio CE, Kerkis A, Martins DS, Zucconi E, Fonseca SA, et al. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: local or systemic? J Transl Med. 2008;6:35.","journal-title":"J Transl Med"},{"key":"4594_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","volume":"15","author":"M Ullah","year":"2019","unstructured":"Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. 2019;15:421\u201338.","journal-title":"iScience"},{"key":"4594_CR30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/PHM.0000000000001500","volume":"99","author":"M Rodr\u00edguez-Cruz","year":"2020","unstructured":"Rodr\u00edguez-Cruz M, Almeida-Becerril T, Atilano-Miguel S, C\u00e1rdenas-Conejo A, Bernabe-Garc\u00eda M. Natural history of serum enzyme levels in Duchenne muscular dystrophy and implications for clinical practice. Am J Phys Med Rehabil. 2020;99:1121\u20138.","journal-title":"Am J Phys Med Rehabil"},{"key":"4594_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","volume":"83","author":"S Moghadam-Kia","year":"2016","unstructured":"Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016;83:37\u201342.","journal-title":"Cleve Clin J Med"},{"key":"4594_CR32","doi-asserted-by":"crossref","unstructured":"Torres-Torrillas M, Rubio M, Damia E, Cuervo B, Del Romero A, Pel\u00e1ez P et al. Adipose-derived mesenchymal stem cells: a promising tool in the treatment of musculoskeletal diseases. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20123105"},{"key":"4594_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13287-023-03337-0","volume":"14","author":"Y Nitahara-Kasahara","year":"2023","unstructured":"Nitahara-Kasahara Y, Nakayama S, Kimura K, Yamaguchi S, Kakiuchi Y, Nito C, et al. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy. Stem Cell Res Ther. 2023;14:108.","journal-title":"Stem Cell Res Ther"},{"key":"4594_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.nmd.2018.09.002","volume":"28","author":"M Baumann","year":"2018","unstructured":"Baumann M, Gumpold C, Mueller-Felber W, Schoser B, Haberler C, Loescher WN, et al. Pattern of myogenesis and vascular repair in early and advanced lesions of juvenile dermatomyositis. Neuromuscul Disord. 2018;28:973\u201385.","journal-title":"Neuromuscul Disord"},{"key":"4594_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1083\/jcb.200108071","volume":"157","author":"ER Barton","year":"2002","unstructured":"Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Muscle-specific expression of insulin-like growth factor I counters muscle decline in Mdx mice. J Cell Biol. 2002;157:137\u201348.","journal-title":"J Cell Biol"},{"key":"4594_CR36","doi-asserted-by":"publisher","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","volume":"7","author":"AS Rosenberg","year":"2015","unstructured":"Rosenberg AS, Puig M, Nagaraju K, Hoffman EP, Villalta SA, Rao VA, et al. Immune-mediated pathology in Duchenne muscular dystrophy. Sci Transl Med. 2015;7:299rv4.","journal-title":"Sci Transl Med"},{"key":"4594_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature11824","volume":"494","author":"H Braum\u00fcller","year":"2013","unstructured":"Braum\u00fcller H, Wieder T, Brenner E, A\u00dfmann S, Hahn M, Alkhaled M, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature. 2013;494:361\u20135.","journal-title":"Nature"},{"key":"4594_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ccr.2009.12.043","volume":"17","author":"M Reimann","year":"2010","unstructured":"Reimann M, Lee S, Loddenkemper C, D\u00f6rr JR, Tabor V, Aichele P, et al. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell. 2010;17:262\u201372.","journal-title":"Cancer Cell"},{"key":"4594_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13287-017-0475-8","volume":"8","author":"CE Rodrigues","year":"2017","unstructured":"Rodrigues CE, Capcha JM, de Bragan\u00e7a AC, Sanches TR, Gouveia PQ, de Oliveira PA, et al. Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury. Stem Cell Res Ther. 2017;8:19.","journal-title":"Stem Cell Res Ther"},{"key":"4594_CR40","doi-asserted-by":"crossref","unstructured":"Liao CM, Luo T, von der Ohe J, de Juan Mora B, Schmitt R, Hass R. Human MSC-derived exosomes reduce cellular senescence in renal epithelial cells. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms222413562"},{"key":"4594_CR41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3727\/096368914X678599","volume":"24","author":"EM Lee","year":"2015","unstructured":"Lee EM, Kim AY, Lee EJ, Park JK, Lee MM, Hwang M, et al. Therapeutic effects of mouse adipose-derived stem cells and losartan in the skeletal muscle of injured Mdx mice. Cell Transpl. 2015;24:939\u201353.","journal-title":"Cell Transpl"},{"key":"4594_CR42","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130:1715\u201325.","journal-title":"Int J Cancer"},{"key":"4594_CR43","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1242\/jcs.026633","volume":"121","author":"Q Gan","year":"2008","unstructured":"Gan Q, Huang J, Zhou R, Niu J, Zhu X, Wang J, et al. PPAR{gamma} accelerates cellular senescence by inducing p16INK4{alpha} expression in human diploid fibroblasts. J Cell Sci. 2008;121:2235\u201345.","journal-title":"J Cell Sci"},{"key":"4594_CR44","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1128\/MCB.15.7.3823","volume":"15","author":"K Guo","year":"1995","unstructured":"Guo K, Wang J, Andr\u00e9s V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995;15:3823\u20139.","journal-title":"Mol Cell Biol"},{"key":"4594_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-\u03b2 signaling in health, disease and therapeutics. Signal Transduct Target Therapy. 2024;9:61.","journal-title":"Signal Transduct Target Therapy"},{"key":"4594_CR46","doi-asserted-by":"crossref","unstructured":"Ren M, Yao S, Chen T, Luo H, Tao X, Jiang H et al. Connective tissue growth factor: regulation, diseases, and drug discovery. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms25094692"},{"key":"4594_CR47","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1073\/pnas.1000830107","volume":"107","author":"K Bedelbaeva","year":"2010","unstructured":"Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, Leferovich J, et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl Acad Sci U S A. 2010;107:5845\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4594_CR48","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1172\/JCI83404","volume":"126","author":"G Rackov","year":"2016","unstructured":"Rackov G, Hern\u00e1ndez-Jim\u00e9nez E, Shokri R, Carmona-Rodr\u00edguez L, Ma\u00f1es S, \u00c1lvarez-Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-\u03baB and IFN-\u03b2. J Clin Invest. 2016;126:3089\u2013103.","journal-title":"J Clin Invest"},{"key":"4594_CR49","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/mt.2015.66","volume":"23","author":"J Tonkin","year":"2015","unstructured":"Tonkin J, Temmerman L, Sampson RD, Gallego-Colon E, Barberi L, Bilbao D, et al. Monocyte\/Macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol Ther. 2015;23:1189\u2013200.","journal-title":"Mol Ther"},{"key":"4594_CR50","doi-asserted-by":"publisher","first-page":"E709","DOI":"10.1152\/ajpendo.00662.2007","volume":"294","author":"K Strle","year":"2008","unstructured":"Strle K, McCusker RH, Johnson RW, Zunich SM, Dantzer R, Kelley KW. Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1beta. Am J Physiol Endocrinol Metab. 2008;294:E709\u201318.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4594_CR51","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1038\/s41598-017-04766-7","volume":"7","author":"W-J Song","year":"2017","unstructured":"Song W-J, Li Q, Ryu M-O, Ahn J-O, Ha Bhang D, Chan Jung Y, et al. TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates DSS-induced colitis by inducing M2 macrophage polarization in mice. Sci Rep. 2017;7:5187.","journal-title":"Sci Rep"},{"key":"4594_CR52","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3389\/fimmu.2019.02131","volume":"10","author":"L-H Ouisse","year":"2019","unstructured":"Ouisse L-H, Remy S, Lafoux A, Larcher T, Tesson L, Chenouard V, et al. Immunophenotype of a rat model of duchenne\u2019s disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment. Front Immunol. 2019;10:2019.","journal-title":"Front Immunol"},{"key":"4594_CR53","doi-asserted-by":"publisher","first-page":"1094359","DOI":"10.3389\/fphys.2023.1094359","volume":"14","author":"M Sato","year":"2023","unstructured":"Sato M, Goto M, Yamanouchi K, Sakurai H. A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation. Front Physiol. 2023;14:1094359.","journal-title":"Front Physiol"},{"key":"4594_CR54","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1089\/hum.2024.013","volume":"35","author":"S Baine","year":"2024","unstructured":"Baine S, Wier C, Lemmerman L, Cooper-Olson G, Kempton A, Haile A, et al. Long-term survival and myocardial function following systemic delivery of delandistrogene moxeparvovec in DMD(MDX) rats. Hum Gene Ther. 2024;35:978\u201388.","journal-title":"Hum Gene Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04594-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:51:46Z","timestamp":1757443906000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4594"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04594-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Ethics Committees of Tokyo Women\u2019s Medical University and The University of Tokyo in Japan (approval number AE21-044; study title: \u201cInvestigation of Neonatal Stem Cell Transplantation in Duchenne Muscular Dystrophy Rats\u201d, approval date: March 18, 2021). Animals were handled in accordance with guidelines from the Science Council of Japan. This study was conducted following the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no financial or non-financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}